Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Receptor Tyrosine Kinase Inhibitor R1530

Known as: MAI R1530, R1530 
A pyrazolobenzodiazepine small molecule with potential antiangiogenesis and antineoplastic activities. Mitosis-angiogenesis inhibitor (MAI) R1530… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
A new series of 7,8-disubstituted pyrazolobenzodiazepines based on the lead compound 1 have been synthesized and evaluated for… Expand
Is this relevant?
2011
2011
PurposeThis study describes the antiproliferative activity of the multikinase inhibitor R1530 in vitro and its antitumor and anti… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?
2010
2010
Polyploidy results from deregulated cell division and has been considered an undesirable event leading to increased mutation rate… Expand
Is this relevant?
2009
2009
e16124 Background: R is a multikinase inhibitor currently in phase I clinical testing. Its inhibitory profile includes several… Expand
Is this relevant?
2009
2009
e14629 Background: R1530 is a multikinase inhibitor currently in clinical phase I testing. Its inhibitory profile includes… Expand
Is this relevant?
2007
2007
A242 R1530 is a multikinase inhibitor with both antitumor and antiangiogenic properties currently in Phase I clinical testing… Expand
Is this relevant?